Best Traditional Pharmaceuticals Companies in New Jersey, United States
The 71 best Traditional Pharmaceuticals companies in New Jersey, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Amneal.
Our analysis of 50 Traditional Pharmaceuticals companies
$3.2b in tracked funding; 51% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2016.
Ranked: Best Traditional Pharmaceuticals companies in New Jersey
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Amneal Manufacturer of generics formulations | $269M | 91 mo ago | Public | Chintu Patel Co-Chief Executive Officer | 2002 | WordPressApple iCloud MailMySQL+28 | — | — |
| 2 | The Alvogen Developer and marketer of pharmaceutical products | $156M | 59 mo ago | Acquired | Lisa Graver Chief Executive Officer | 2009 | PrismicSentryNode.js+17 | 8 patents Controlled-release oral tablet formulations for pregabalin drug delivery | — |
| 3 | Slayback Pharmaceuticals Manufacturer of specialty generics drugs | $110M | 77 mo ago | Acquired | — | 2011 | — | — | — |
| 4 | JHP Pharmaceuticals Dependable pharmaceutical company providing generics, contract manufacturing, and pharmaceutical services | $78M | 179 mo ago | Acquired | — | 2007 | — | — | — |
| 5 | EKR Therapeutics Manufacturer of oncology based products and others generics | $63M | 219 mo ago | Acquired | Richard DeSimone Co-Founder | 2005 | — | — | — |
| 6 | Leading Pharma Manufacturer of generic pharmaceutical products for the US market | $40M | 101 mo ago | Series B | Ron Gold CEO | 2014 | JoomlaPHPBootstrap+10 | — | — |
| 7 | Bionpharma Manufacturer & supplier of prescription and OTC generic products | $37M | 126 mo ago | Series A | Venkat Krishnan President & CEO | 2014 | WordPressMySQLPHP+15 | — | — |
| 8 | Amerigen Pharma Developer of generics with focus in orally delivered products | $35M | 126 mo ago | Deadpooled | — | 2007 | — | — | — |
| 9 | Zennova Manufacturer of drugs | $14M | 35 mo ago | Series B | Dahai Guo Co-Founder & CEO | 2014 | — | 3 patents Analyzing dissolution and solubility of poorly soluble compounds in complex media | — |
| 10 | Guardian Drug Manufacturer of over-the-counter pharmaceutical and nutritional products | $10M | 100 mo ago | Series A | Arvind Dhruv Founder & CEO | 1984 | WordPressMySQLPHP+19 | — | — |
| 11 | Appco Pharma US-based pharmaceutical company specializing in drug development, manufacturing, and commercialization | $5M | 75 mo ago | Funding Raised | Rajendra Appalaneni Founding Member | 2014 | Windows ServerBootstrapMicrosoft ASP.NET+9 | — | — |
| 12 | Avicenna Therapeutics Provider of pharmaceutical products | $3M | 41 mo ago | Seed | Jan Scicinski Founder President and CEO | 2016 | — | — | — |
| 13 | Bausch & Lomb Developer of pharmaceutical products and instruments for ophthalmology | $973K | 37 mo ago | Public | John Bausch Co-Founder | 1853 | SalesforceBootstrapStripe+21 | 3,602 patents Patents concentrated in computing, sensing & instrumentation | — |
| 14 | SAPHTx Manufacturer of COVID-19 drugs | $256K | 66 mo ago | Funding Raised | Vivek Kumar Founder | 2018 | — | — | — |
Top 12 Traditional Pharmaceuticals companies in New Jersey
#1
Series B · Princeton, New Jersey · founded 2014$13.9Mraised▾
Manufacturer of drugs
- Jul 2023Series B$13.9M
- Aug 2021Series A—
#2
Acquired · Morristown, New Jersey · founded 2009 · 2800 employees$155.9Mraised▾
Developer and marketer of pharmaceutical products. This company focuses on developing, in-licensing, manufacturing, and marketing pharmaceutical products. Its portfolio includes generic drugs, branded products, injectables, and complex, high-value medications such as complex inhalation therapies and strategic 505(b)(2) products. The company has a robust research and development program to support its growing pipeline. It also emphasizes ethical business practices and transparency in its interactions with healthcare providers.
- Jun 2021Series D$100M
- 2012Series C$55.9M
#3
Public · Bridgewater, New Jersey · founded 1853 · 1681 employees$973Kraised▾
Developer of pharmaceutical products and instruments for ophthalmology. The company's portfolio includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments.
- Apr 2023Post IPO—
- Jul 2015Grant (prize money)$973K
#4
Seed · Princeton, New Jersey · founded 2016$3Mraised▾
Provider of pharmaceutical products
- Dec 2022Seed$3M
#5
Public · Bridgewater, New Jersey · founded 2002 · 1441 employees$269.2Mraised▾
Amneal Pharmaceuticals is a fully-integrated pharmaceutical company focused on the development, manufacture, and distribution of generic and specialty drug products. The company has an extensive portfolio of approximately 250 generic medicines and is expanding its portfolio to include complex dosage forms including biosimilars in a broad range of therapeutic areas. The company also markets a portfolio of branded pharmaceutical products through its specialty segment focused principally on the central nervous system and endocrine disorders.
- Nov 2018Post IPO$19.2M
- Feb 2015Conventional Debt$250M
- 2005Series A—
#6
Acquired · West Windsor Township, New Jersey · founded 2011 · 7 employees$110Mraised▾
Slayback Pharmaceuticals is a specialty generics manufacturer focusing on complex formulations such as complex injectables, non-solid, sterile oral formulations, etc. They obtained the FDA approval for a Generic Zovirax (Acyclovir) Ointment for genital herpes and in limited non-life-threatening mucocutaneous Herpes simplex virus infections in immunocompromised patients. It works on the following formulations: sterile 505b2 injectable solutions, sterile emulsions, sterile suspensions, sterile microspheres, complex topical products, foams and aerosols, controlled substances with complex delivery systems, and oral products with higher bioavailability.
- Jan 2020Series B$50M
- Dec 2016Series A$60M
#7
Acquired · Bedminster, New Jersey · founded 2005 · 33 employees$63Mraised▾
EKR Therapeutics is a specialty pharmaceutical company focused on acquiring, developing, and commercializing prescription products and oncology supportive care. It focuses on various areas, including oral mucositis, stomatitis, dry mouth/xerostomia, nutritional issues, cachexia, skin reactions, bone marrow depression, bone complications, acute and chronic pain, nausea, vomiting, and diarrhea.
- Mar 2008Series C$50M
- Mar 2008Conventional Debt$95M
- Aug 2007Series C$13M
#8
Series B · Fairfield, New Jersey · founded 2014 · 161 employees$40Mraised▾
Manufacturer of generic pharmaceutical products for the US market. This company develops, manufactures, and distributes high-quality generic pharmaceuticals to various channels, including drugstore chains, distributors, wholesalers, and government agencies. Products are available in numerous dosage forms and therapeutic areas. The company focuses on providing safe and effective medications. Its operations encompass the entire process, from initial development to delivery to the end customer. A dedicated team ensures stringent regulatory compliance throughout the manufacturing and distribution process.
- Jan 2018Series B$40M
#9
Acquired · Parsippany Troy Hills, New Jersey · founded 2007 · 450 employees$78Mraised▾
Dependable pharmaceutical company providing generics, contract manufacturing, and pharmaceutical services. The company focuses on safety and effective pharmaceutical studies, offering a range of services from product development to delivery. They provide generic products, contract manufacturing, and pharmaceutical services. Their expertise includes preclinical testing, clinical trials, and regulatory compliance. They offer a wide range of pharmaceutical goods, including prescription medications, vitamins, and supplements. The company emphasizes quality assurance, customer service, and discreet delivery. They collaborate with healthcare providers and scientific organizations to ensure product quality and patient safety. They also offer digital support, including online consultations and prescription refills. The company aims to provide affordable medications and improve patient outcomes through research, development, and responsible pharmaceutical practices.
- Jul 2011Conventional Debt$78M
#10
Series A · Princeton, New Jersey · founded 2014 · 38 employees$37.2Mraised▾
Manufacturer & supplier of prescription and OTC generic products. The company develops and distributes generic pharmaceutical products and is accomplished in the areas of product development, regulatory affairs, quality management, sales and distribution, and supply chain management, enabling clients to get soft gel capsules in the US market.
- Dec 2015Series A$6.5M
- May 2015Series A$30.7M
#11
Deadpooled · Lyndhurst, New Jersey · founded 2007 · 24 employees$35Mraised▾
Amerigen Pharmaceuticals is a group of companies engaged the development of generics with the focus in orally delivered drugs. Its US regulatory and commercial activities within the group are conducted by the units in New Jersey and its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals. It has an active portfolio of products under development, filed, or intended for filing, as ANDA's with the US FDA and the Chinese CFDA.
- Dec 2015Conventional Debt$15M
- Jan 2015PE$35M
#12
Funding Raised · Somerset, New Jersey · founded 2014 · 123 employees$5Mraised▾
US-based pharmaceutical company specializing in drug development, manufacturing, and commercialization. It offers comprehensive services from product and formulation development to analytical development and manufacturing. The company focuses on high-quality, affordable drug products, including immediate and controlled-release oral solid dosage forms, bi-layered tablets, and various manufacturing services like granulation, direct compression, and roller compaction. Analytical services include method development, validation, and forced degradation studies. The company is committed to "execution with precision" and maintains high-quality standards. It provides a one-stop-shop solution for pharmaceutical needs, supporting the development and commercialization of complex drugs.
- Mar 2020Conventional Debt$5M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Traditional Pharmaceuticals coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Drug Discovery is moving in the United States
A read on the academic research around Drug Discovery — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 9,593 United States-affiliated papers.
- Harvard University331
- University of North Carolina at Chapel Hill232
- Purdue University West Lafayette200
- Cornell University172
- Stanford University170
- Computational biology126→901
- Small molecule41→351
- Chemical space26→319
- Virtual screening24→288
- Bioinformatics14→216
- Computational biology102→599
- Docking (animal)27→275
- Drug development27→259
- Virtual screening29→235
- In silico12→211
- Computational biology75→206
- Drug development47→176
- Bioinformatics18→102
- Data science20→89
- Disease13→78
Where drug discovery is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing drug discovery patents in the United States
United States drug discovery patent filing is accelerating — 762,525 filings from 8,000 assignees (2016–2025), led by UNIV California, Genentech, Bristol Myers Squibb; annual filings 69033→70331.
- UNIV California22029
- Genentech19677
- Bristol Myers Squibb19149
- Procter & Gamble16492
- Lilly ELI15535
- Pfizer15334
- Merck Sharp & Dohme14790
- Amgen14371
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.